Business

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless otherwise stated.

articleIm Cannabis Corp.May 13, 20265/company/im-cannabis-corp/news/im-cannabis-corp-announces-first-quarter-2026-financial-results
IM Cannabis Corp. Announces First Quarter 2026 Financial Results

About this update from Im Cannabis Corp.

[{"type":"text","content":"TORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless otherwise stated.","length":357,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/IM Cannabis Corp.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/IM Cannabis Corp.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/843332726b276681550e34319acab3d1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/DbHPIwLh5rBfgXatPBZH8w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/843332726b276681550e34319acab3d1","width":400,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/CZqei1rwDl666hnQzwrXTA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/843332726b276681550e34319acab3d1","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"For the three months ended March 31, 2026, the Company recorded revenues of $8.7 million, gross profit of $1.4 million, operating loss of $1.7 million, and a net loss of $2.5 million, or $0.38 per share. The Company also continued to advance its cost optimization initiatives, reducing general and administrative expenses by 22% year-over-year. The Company also maintained its focus on working capital discipline and liquidity management, supported by convertible note financings completed during the quarter ended March 31, 2026, and additional financings completed following quarter-end.","length":589,"tagName":"p"},{"type":"text","content":"Management remains focused on operational efficiencies, disciplined working capital management, and the continued evaluation of strategic opportunities to enhance the Company's long-term growth.","length":198,"tagName":"p"},{"type":"text","content":"The full Interim Financial Statements and Management's Discussion and Analysis are available on SEDAR+ and EDGAR.","length":117,"tagName":"p"},{"type":"text","content":"About IMC ","...

More updates from Im Cannabis Corp.

the CompanyIsraelmedical cannabisForward-Looking Statementsliquidity managementCompanyIM Cannabis Corp.working capital